868 results on '"Barnham, Kevin J."'
Search Results
2. ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
3. Multi-omics characterization of highly enriched human plasma extracellular vesicles.
4. Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
5. Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles.
6. Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics.
7. Optimization of plasma extracellular vesicle enrichment for in‐depth lipidomic profiling in Alzheimer’s disease
8. Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics
9. Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
10. Utilizing18F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease
11. Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice
12. Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
13. Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
14. Using 18F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
15. Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism
16. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study
17. Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease
18. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
19. Free Radicals, Metal Ions, and Aβ Aggregation and Neurotoxicity
20. The Aβcentric Pathway of Alzheimer’s Disease
21. Copper Coordination by β-Amyloid and the Neuropathology of Alzheimer’s Disease
22. Ablation of tau causes an olfactory deficit in a murine model of Parkinson’s disease
23. Neurological Dysfunction in Early Maturity of a Model for Niemann–Pick C1 Carrier Status
24. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
25. The Amyloid Precursor Protein Copper Binding Domain Histidine Residues 149 and 151 Mediate APP Stability and Metabolism
26. The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy
27. Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington’s disease
28. Anti-Aβ antibody target engagement: a response to Siemers et al.
29. Extracellular vesicular lipids as biomarkers for the diagnosis of Alzheimer’s disease
30. Quantitative proteomics of detergent insoluble tangles derived from Alzheimer’s disease brains
31. Increasing Cu Bioavailability Inhibits Aβ Oligomers and Tau Phosphorylation
32. Platinum-Based Inhibitors of Amyloid-β as Therapeutic Agents for Alzheimer's Disease
33. NMR Spectroscopy of Platinum Drugs: From DNA to Body Fluids
34. Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity
35. ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
36. Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?
37. Cu2+ Coordination of Covalently Cross-linked β-Amyloid Dimers
38. Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease
39. Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation
40. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease
41. Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples
42. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer’s disease
43. Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex
44. Metals in Alzheimer's and Parkinson's Diseases
45. Generation of soluble oligomeric β-amyloid species via copper catalyzed oxidation with implications for Alzheimer’s disease: A DFT study
46. Copper and zinc bis(thiosemicarbazonato) complexes with a fluorescent tag: synthesis, radiolabelling with copper-64, cell uptake and fluorescence studies
47. Amyloid‐β and monocytes in Alzheimer's disease.
48. Electron paramagnetic resonance characterization of the copper-resistance protein PcoC from Escherichia coli
49. Neurotoxicity in Alzheimer’s disease: is covalently crosslinked Aβ responsible?
50. Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.